As of 2025-10-23, the Relative Valuation of Haemonetics Corp (HAE) is 104.95 USD. This relative valuation is based on P/E multiples. With the latest stock price at 51.34 USD, the upside of Haemonetics Corp based on Relative Valuation is 104.4%.
The range of the Relative Valuation is 94.21 - 111.73 USD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | 26.7x - 31.6x | 29.7x |
| Fair Price | 94.21 - 111.73 | 104.95 |
| Upside | 83.5% - 117.6% | 104.4% |
| Date | P/E |